Novo Nordisk will distribute its weight-loss drugs through Hims & Hers Health’s digital platform, driving a sharp surge in the telehealth company’s stock.
Hims & Hers Health’s share price surged more than 40% following news that Novo Nordisk, the Danish pharmaceutical company known for its weight-loss drugs, will distribute those medications through the Hims & Hers telehealth platform. The announcement highlights the growing intersection between digital healthcare services and major pharmaceutical firms as online platforms become a significant channel for prescription drug distribution.